Transvenous internal cardioversion for atrial fibrillation: A randomized study on defibrillation threshold and tolerability of asymmetrical compared with symmetrical shocks

International Journal of Cardiology

Volumn 71, Issue 1, 1999, Pages 63-69

  Boriani, Giuseppe ^a   Biffi, Mauro ^a   Zannoli, Romano ^a   Branzi, Angelo ^a   Magnani, Bruno ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Atrial cardioversion; Atrial fibrillation; Pain; Shock; Waveform

Indexed keywords

ANESTHETIC AGENT; SEDATIVE AGENT;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEFIBRILLATOR; ENERGY; FEMALE; FLUOROSCOPY; HEART ATRIUM FIBRILLATION; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WAVEFORM;

ADULT; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CROSS-OVER STUDIES; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; MALE; MIDDLE AGED; WARFARIN;

EID: 0032836568     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(99)00116-3     Document Type: Article

References (30)

1. Cooper R.A.S., Alferness C.A., Smith W.M., Ideker R.E. Internal cardioversion of atrial fibrillation in sheep. Circulation. 87:1993;1673-1686.
2. Ayers G.M., Alferness C.A., Ilina M., Wagner D.O., Sirokman W.A., Adams J.M., Griffin J.C. Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation. Circulation. 89:1994;413-422.
3. Alt E., Schmitt C., Ammer R., Coenen M., Fotuhi P., Karch M., Blasini R. Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation. PACE. 17:1994;1067-1078.
4. Murgatroyd F.D., Slade A.K.B., Sopher S.M., Rowland E., Ward D.E., Camm A.J. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol. 25:1995;1347-1353.
5. Levy S., Ricard P., Lau C.P., Lok N.S., Camm J., Murgatroyd F.D., Jordaens L., Kappenberger L.J., Brugada P., Ripley K.L. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. J Am Coll Cardiol. 29:1997;750-755.
6. Levy S., Ricard P., Gueunoun M., Yapo F., Trigano J., Mansouri C., Paganelli F. Low energy cardioversion of spontaneous atrial fibrillation. Circulation. 96:1997;253-259.
7. Cooper R.A.S., Johnson E.E., Wharton J.M. Internal atrial defibrillation in humans: the improved efficacy of biphasic waveforms and the importance of phase duration. Circulation. 95:1997;1487-1496.
8. Boriani G., Biffi M., Bronzetti G., Ayers G.M., Zannoli R., Branzi A., Capucci A., Magnani B. Efficacy and tolerability in fully conscious patients of transvenous low energy internal atrial cardioversion for atrial fibrillation. Am J Cardiol. 81:1998;241-244.
9. Cooper R.A.S., Plumb V.J., Epstein A.E., Kay G.N., Ideker R.E. Marked reduction in internal atrial defibrillation thresholds with dual-current pathways and sequential shocks in humans. Circulation. 97:1998;2527-2535.
10. Sopher S.M., Murgatroyd F.D., Slade A.K.D., Blankoff I., Rowland E., Ward D.E., Camm A.J. Low energy internal cardioversion of atrial fibrillation resistant to transthoracic shocks. Heart. 75:1996;635-638.
11. Schmitt C., Alt E., Plewan A., Ammer R., Leibig M., Karch M., Schomig A. Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. J Am Coll Cardiol. 28:1996;994-999.
12. Cooper R.A.S., Johnson E.E., Kanter R.J., Merrill J.J., Sorentino R.A., Wharton J.M. Internal cardioversion in two patients with atrial fibrillation refractory to external cardioversion. PACE. 19:1996;872-875.
13. Levy S., Camm J. An implantable atrial defibrillator: An impossible dream? Circulation. 87:1993;1769-1772.
14. Tavernier R, Jordaens L for The Metrix Investigators: The clinical experience with the Metrix automatic implantable atrial defibrillator. J Am Coll Cardiol 1998; 31 (Suppl A), 195A abstract.
15. Wellens HJJ, Lau CP, Luderitz B, Akhtar M, Waldo AL, Camm AJ, Timmermans C, Tse HF, Jung W, Jordaens L, Ayers G, for the Metrix Investigators: Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation 1998;98:1651-1656.
16. Laupacis A., Albers G., Dalen J., Dunn M., Feinberg W., Jacobson A. Antithrombotic therapy in atrial fibrillation. Chest. 108:1995;352S-359S.
17. Luceri R.M., Accorti P.R. Temporary transvenous cardioversion and defibrillation: a new method for practical tachyarrhythmia management. PACE. 20:1997;168-172.
18. Ammer R., Alt E., Ayers G., Schmitt C., Pasquantonio J., Schmidt M., Putter K., Schomig A. Pain threshold for low energy intracardiac cardioversion of atrial fibrillation with low or no sedation. PACE. 20:1997;230-236.
19. Tommassoni G., Newby K.H., Kearney M.M., Brandon M.J., Barold H., Natale A. Testing different biphasic waveforms and capacitances: effect on atrial defibrillation threshold and pain perception. J Am Coll Cardiol. 28:1996;695-699.
20. Jung W., Tebbenjohanns J., Wopert C., Luberitz B. Safety, efficacy and pain perception of internal defibrillation in humans. Circulation. 92:1995;I-472.
21. Steinhaus D.M., Cardinal D., Mongeon L., Mattson L., Waters M., Foley L., Corrigan S. Atrial defibrillation: are low energy shocks acceptable to patients? PACE. 19:1996;625 abstract.
22. Jung W., Pfeiffer D., Wolpert C., Pizzulli L., Fehnske W., Schumaker B., Lewalter T., Omran H., Korte D., Luderitz B. Which patients do benefit from an implantable atrial defibrillator? J Am Coll Cardiol. 27:1996;301 abstract.
23. Heisel A., Jung J., Schubert B., Kollner V., Michel U. Internal atrial defibrillation by using a new single atrial lead system and evaluation of two new biphasic waveforms. in. Antonioli G.E. Pacemaker leads 1997. 1997;567-572 Monduzzi, Bologna.
24. Keane D. Impact of pulse characteristics on atrial defibrillation energy requirements. PACE. 17:1994;1048-1057.
25. Harbinson M.T., Allen J.D., Imam Z., Dempsky G., MacAnderson J., Ayers G.M., Adgey A.A.J. Rounded biphasic waveform reduces energy requirements for transvenous catheter cardioversion of atrial fibrillation and flutter. PACE. 20:1997;226-229.
26. Harbinson M.T., Imam Z., McEneaney D.J., Touton T.G., Burgess L., Ayers G.M., Ripley K., Dempsey G., Anderson J., Adgey A.A.J. Patient discomfort after for transvenous catheter cardioversion of atrial tachyarrhythmias with rounded waveforms Initial results. Circulation. 94:1996;I-67 abstract.
27. Timmermans C., Rodriguez L.M., Smeets J.L.R.M., Wellens H.J.J. Immediate reinitiation of atrial fibrillation following internal atrial defibrillation. J Cardiovasc Electrophysiol. 9:1998;122-128.
28. Boriani G., Biffi M., Capucci A., Bronzetti G., Ayers G.M., Zannoli R., Branzi A., Magnani B. Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation. J Am Coll Cardiol. 33:1999;333-341.
29. Lok N.S., Lau C.P., Tang Y.W. Variation of defibrillation threshold in repeated transvenous atrial defibrillation. PACE. 18:1995;850 abstract.
30. Santini M., Pandozi C., Toscano S., Castro A., Altamura G., Iesi A., Villani M. Changes in intracardiac atrial cardioversion at rest and during exercise. J Am Coll Cardiol. 29:1997;576-581.